Novartis AG vs Twilio Inc — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Twilio Inc trades at $195.59 (market cap $31.15B). The key difference: Novartis AG is far larger — about 9.3× Twilio Inc's market cap, and Novartis AG pays a 3.17% dividend while Twilio Inc pays none. Which is the better fit depends on your goals.
| NVS | TWLO | |
|---|---|---|
Market Cap | $290.25B | $31.15B |
Sector | Health | Technology |
52-Week High | $168.62 | $236.64 |
52-Week Low | $113.50 | $92.44 |
Enterprise Value | $330.27B | $29.87B |
Dividend Yield | 3.17% | — |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →Twilio Inc. is a cloud-based communication platform-as-a-service company offering communication building blocks that allow for a fully customized customer engagement experience spanning voice, video, chat, and SMS messaging. It does this through various application programming interfaces, or APIs, and prebuilt solution applications aimed at improving customer engagement. The company leverages its Super Network, a global network of carrier relationships, to facilitate high-speed, cost-effective communication.
Read more on TWLO →